Glucagon-like peptide-1 agonists are a class of medications utilized in the treatment of type 2 diabetes and obesity. This activity will highlight the indications, mechanism of action, administration, adverse effect profile, and contraindications for these drugs. The use of an interprofessional team of nurses, primary care providers, pharmacists, and endocrinologists remains pertinent to care for patients prescribed this class of medications.

**Objectives:**
- Review the mechanism of action of GLP-1 receptor agonists. 
- Identify the potential adverse effects of GLP-1 receptor agonists. 
- Outline the methods of administration for GLP-1 analogs and the clinical monitoring necessary for patients prescribed GLP-1 receptor agonists. 
- Explain the importance of collaboration and communication among an interprofessional healthcare team to improve outcomes for patients receiving GLP-1 agonists.